Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.
Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.
Aveanna Healthcare Holdings Chief Financial Officer Matthew Buckhalter reported equity awards in company stock. On February 14, 2026, he acquired 15,213 shares of common stock upon vesting of performance-based restricted stock units from the company’s 2022 long-term incentive awards and 46,875 shares upon vesting of performance-based restricted stock units from 2023 long-term incentive awards, both at a price of $0 per share.
He also received a grant of 66,205 stock-settled restricted stock units subject to three-year cliff vesting. Following these award-related acquisitions, he directly owned 565,273 shares of Aveanna Healthcare common stock.
Aveanna Healthcare Holdings director Erica Schwartz reported an equity award. On 02/14/2026, she acquired 18,916 shares of common stock through a grant of stock-settled restricted stock units at a price of $0. The units are subject to one-year cliff vesting. Following this grant, she directly holds 276,414 shares.
Shaner Jeff reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 715,229 shares. Following the reported transactions, holdings were 3,112,801 shares.
Stewart Deborah reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 79,099 shares. Following the reported transactions, holdings were 331,622 shares.
Cunningham Patrick A. reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 91,797 shares. Following the reported transactions, holdings were 386,915 shares.
Windley Rodney D reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 289,947 shares. Following the reported transactions, holdings were 2,318,234 shares.
Reisz Edwin C. reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 287,457 shares. Following the reported transactions, holdings were 1,609,100 shares.
RODGERS STEVEN E reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 18,916 shares. Following the reported transactions, holdings were 312,414 shares.
Perchik Jerry reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 49,653 shares. Following the reported transactions, holdings were 440,530 shares.
GANZI VICTOR F reported acquisition or exercise transactions in this Form 4 filing.
Aveanna Healthcare director Victor F. Ganzi reported an equity award of 18,916 common shares through a stock-settled restricted stock unit grant. The grant was made at a price of $0 per share and is subject to one-year cliff vesting. Following this award, Ganzi directly beneficially owns 502,522 shares of Aveanna Healthcare common stock.